Weak growth masks CapEx bet; energy costs bite
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Guided 18% CAGR; delivered 3.2% YoY. Margin expansion promised; compressed QoQ. Long-term narrative intact but unquantified.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q2 shows weak 3.2% YoY growth and 21.4% PAT decline despite stated margin gains, driven by ₹4.78 Cr energy/freight headwind. Management reaffirms 18% CAGR but with heavy hedging and no near-term targets. The long-term CapEx/mining/solar narrative is intact, but near-term execution risk and structural cost inflation are material headwinds. Hold pending clarity on mining ramp and solar benefit timing.
₹238.16 Cr
Revenue · +3.2% YoY₹13.64 Cr
Reported PAT · −21.4% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Revenue growth returned in Q2; return to year-on-year growth
MISS3.2% YoY growth delivered, vs 18% CAGR prior guidance—massive shortfall
Gross margin rose ~80 bps for the half; 47.7% in Q2
OVERSTATED47.7% vs 47.6% YoY—stable, not expanding; energy/freight costs offset gains
18% CAGR is definitely in place with CapEx and mining
METQ2 shows 3.2% growth; reaffirmation is hedged ('should help us regain'), no near-term proof
Specialty products now ~1/3 of revenue with better margins
MixedAnalyst-estimated 1/3; management confirms shift underway but PAT margin compressed YoY
Earnings quality
What changed since the last call
Revenue growth guidance credibility
Downgrade18% CAGR reaffirmed but hedged as 'should help us regain' vs prior definitive stance. Q2 delivered only 3.2% YoY; no path to 18% visible without major acceleration.
Near-term margin outlook
DowngradeEnergy/freight costs inflated ₹4.78 Cr; EBITDA margin 11.6% vs 13.8% prior year. Solar/mine benefits pushed to FY29; no near-term relief visible.
Specialty product contribution
NewAnalyst-estimated 1/3 of revenue; management confirms growth in double-digit segments (polymers, rubber, construction-chemicals) but paint subdued. Shift underway but not yet moving group PAT.
CapEx clarity
Upgrade₹100 Cr program 30% deployed; ₹12 Cr solar, ₹7 Cr mining. Expect 50% deployed Q3, remaining 15–18 months. Specific project list (solar, quartz, talc, Malaysia) now named with December mine-start dates.
The Q&A
Analysts pressed hard on revenue stall vs peer growth, margin pressure, and lack of near-term specifics. Management deflected on numbers ('unpredictable'), defended product mix as B2B-driven, and deferred upside to FY29. No buyback; focus on reinvestment. Tone was defensive but firm on long-term strategy.
Revenue growth outlook — Harshit Khadka, Robo Capital
Partial18% CAGR is in place with projects and mining reserves. Should regain CAGR within 2–3 years given unpredictability. Current market and cost dynamics make specific figures impossible.
Specialty product mix — Kavya Varma, Apricus Wealth
AnsweredB2B model differs; customers' own price hikes limit our pass-through. Polymers/rubber/construction-chemicals up double-digit; paint subdued. Mix keeps changing quarter to quarter; direct comparison flawed.
Valuation and capital allocation — Kavya Varma, Apricus Wealth
DodgedPromoter stake increase is discussed regularly. No buyback plans now. All options analyzed; decisions via stock exchanges.
Raw material sourcing and mine timing — Kavya Varma, Apricus Wealth
PartialTwo factors at play: imported material (China, Malaysia, Vietnam) and local mines. Supply chain impacts costs heavily. All mines active by FY30; exact cost impact TBD.
Energy/freight cost headwinds H2 FY27 — Amit Bhaiya (via chat)
AnsweredPower costs ₹42→₹56/kg (33%, ₹1.34 Cr). Gas ₹69→₹122/kg (77%, ₹0.62 Cr). Freight ₹2.1→₹2.3K/MT (11%, ₹2.92 Cr). Total ₹4.78 Cr (200 bps). Solar will meet 40% of power by FY29, worth ~₹8 Cr EBITDA/yr.
Solar capex grid tariff and FY28 run-rate benefit — Amit Bhaiya (via chat)
AnsweredSolar grid tariff ~₹3.45–₹3.5/unit (heard). Benefit expected from FY29 onwards once operational. Not FY28 yet.
Capex deployment timing and specialty capacity — Janish Shah
PartialSpecialty products already contributing to margins on consolidated basis (20 Microns Nano in double-digit growth, high profitability). Capex adds calcium carbonate, nano talc, functional additives. Mix of products expanding over 2–3 years.
Order book visibility — Shubham Sahani, RSPN Ventures
DodgedWe don't work on order books. Volume defined by customers on quarterly basis per market conditions and demand. Q3 continues growth trends; Q4 historically strongest quarter.
Segment-level revenue and margins — Shubham Sahani, RSPN Ventures
PartialWill need to contact IR; they'll forward segment-wise breakup.
Mining quality vs competitors — Manish Kela (chat)
DodgedMining grade comparison doesn't work; everyone has access to certain grades, must rely on external sources too. Requirements differ by customer base and use case.
Minford and long-term portfolio — Ashwin Reddy, Samatya Investments
AnsweredMinford dear to portfolio; nurtured from by-products (mineral fertilisers). Now scaling to urban gardens, farmland, residential—new market. Focus on India + Africa export. Slow and steady process. Part of 20 Microns family but not a burden.
Opacifiers and titanium dioxide replacement — Amit Bhaiya (chat)
PartialOpacifiers from 20 Microns and Nano; wide range available. Kaolin, fine calcium carbonates, high-grade opacifiers replace TiO2. Exact share unknown; team to follow up. Exports high-grade barytes under license.
Guidance
18% CAGR over next 3 years (FY27–FY30 implied)
MediumReaffirmed but hedged as 'should help us regain' vs prior confident tone. Contingent on CapEx, mining ramp, specialty uplift. Q2 shows 3.2% YoY; no near-term acceleration evident.
200–250 bps EBITDA expansion (prior guidance from FY26 calls); solar ₹8 Cr (80 bps) from FY29
LowNo explicit reaffirmation on this call. Energy/freight headwinds (200 bps) currently overwhelming. Solar benefit deferred to FY29. Management focused on protecting vs expanding near-term margins.
₹100 Cr CapEx programme; 30% deployed; remaining 70% over next 15–18 months
HighSpecific breakdown: ₹12 Cr solar, ₹7 Cr mining acquisitions committed. Funded via internal accruals + selective debt. Phase-wise quarterly deployment.
Risks the call surfaced
Energy cost inflation
HighPower costs ₹42→₹56/kg (33% YoY); gas ₹69→₹122/kg (77% YoY). Total ₹4.78 Cr impact (200 bps EBITDA). Solar plants will cover only 40% of power demand from FY29.
Revenue growth stall
HighQ2 revenue growth +3.2% YoY vs 18% CAGR guidance. Paints segment flat YoY. Specialty products (1/3 of revenue) growing but not yet offsetting commodity slowdown. Customer growth differential vs peers (FMCG commodities up double-digit) not explained.
CapEx execution risk
Medium₹100 Cr CapEx programme contingent on December 2026 mine production ramp, Q4 FY27 solar commissioning, and Malaysia project scaling. Delays in any major project cascade to margin benefit timeline.
Raw-material import dependence
Medium40% of raw materials imported from China, Malaysia, Vietnam. Dollar pricing and freight volatility amplified by tariff/political risk. Recent tariff hikes on furnace oil and freight cited as 33–77% cost increases.
Pricing power constraints
MediumB2B model limits ability to pass through cost inflation. Customers (paint, polymers, rubber) raised retail prices 3x in 6 months but constrain wholesale price increases. Margin pressure persists even with input cost hikes.
Management
Score 6/10. Transparent on CapEx and mine timelines; evasive on specific revenue/margin targets ('unpredictable markets'). Deflects on segment breakup, order books. CEO defends product mix narrative but avoids quantified commitments. Mixed track record. Delivered 3.2% revenue growth vs 18% CAGR guidance (major miss). Margin compression despite specialty product narrative. CapEx 30% deployed on time; cost discipline (finance cost down 6%). Honesty on headwinds good, but delivery lag concerning.
1 · Q3 FY27 (Dec 2026)
9 MW captive solar plants and talc/quartz mines ramp production; CapEx 50% deployed
2 · Q4 FY27 (Mar 2027)
Solar plants operational; expected ₹8 Cr annual EBITDA benefit; Malaysia project scaling
3 · FY28 (Apr 2027–Mar 2028)
Full CapEx deployment complete, mining capacity doubled, specialty product revenue ramp, margin expansion 200+ bps
Hold pending clarity on mining ramp and solar benefit timing.
20 Microns Q2FY27: consolidated PAT falls 21% YoY on margin compression despite revenue growth
PAT -21.39% YoY · revenue +3.2% · margins compressing
₹238.16 Cr
+3.2% YoY
₹13.64 Cr
-21.39% YoY
5.7%
-1.8pp YoY
₹3.87
20 Microns' consolidated revenue rose 3.2% YoY to ₹238.16 Cr (down 2.7% QoQ from ₹244.72 Cr), but consolidated PAT fell 21.4% YoY to ₹13.64 Cr (down 23.1% QoQ from ₹17.74 Cr); owners'-attributable PAT was ₹13.67 Cr with EPS at ₹3.87 versus ₹4.93 a year ago. Neither this quarter nor the year-ago quarter carried any exceptional item, so the decline is operating in nature, not a base-effect artefact. The two bases diverge materially: standalone PAT fell a much smaller 9.6% YoY to ₹12.68 Cr on standalone revenue of ₹199.79 Cr (+1.1% YoY) — a gap of over 10 percentage points versus the consolidated PAT decline, pointing to drag from the subsidiary layer rather than the parent business.
Q2 FY-2027 vs prior quarters
Net profit margin compressed to 5.70% of total income from 7.47% a year ago and 7.21% last quarter. An EBITDA-style margin (pre-exceptional PBT plus finance cost and depreciation, over revenue from operations) slid to roughly 12.2% from ~14.5% YoY and ~13.8% QoQ — total expenses grew faster (+5.4% YoY) than revenue (+3.2% YoY), so the squeeze sits on the cost line rather than a one-off charge.
The stock went into the print at ₹166.1, down 23.4% over the past month of trading.
Management projects an 18% CAGR revenue growth over the next three years, supported by a INR 100 crore CapEx plan focused on specialty product capabilities, operational productivity, backward integration, and international scaling. They anticipate a 200-250 basis point margin expansion and ROCE improvement to 18-20% wi
— This quarter: missed
Management's May 2026 concall had guided to an 18% three-year revenue CAGR, 200-250bps margin expansion, ROCE improving to 18-20%, and crossing ₹1,000 Cr revenue in the current financial year. This quarter's 3.2% YoY topline growth and margin compression run well short of that path, so guidance is being missed on both the growth and margin legs this quarter. No formal brokerage consensus for this specific quarter was found in search, so the print cannot be benchmarked against street estimates. Separately, auditor notes flag four unreviewed subsidiaries — including the August-2026 acquisition of a 99.99% stake in Shree Shrest Minerals for ₹1.5 Cr — posting a combined ₹(57.42) Lakh quarterly loss that management certifies as immaterial to the group, alongside one larger subsidiary (₹114.4 Cr assets, reviewed by another auditor) that contributed ₹2.21 Cr of PAT.
W1
H2 FY27 revenue run-rate against the ₹1,000 Cr FY27 target — needs ~₹514.5 Cr (+7.3% YoY over H2 FY26's ₹479.51 Cr) after this quarter's 3.2% YoY pace
W2
OPM trajectory versus the guided 200-250bps expansion — this quarter's EBITDA-style margin (~12.2%) ran below both Q1 FY27 (~13.8%) and Q2 FY26 (~14.5%)
W3
Contribution of the newly consolidated subsidiaries, including the August-2026 Shree Shrest Minerals stake, currently posting a combined ₹(57.42) Lakh quarterly loss per auditor note
Consolidated PAT reported as total profit for the period (₹13.64 Cr, pre-NCI, row IX-X) to match the DB's netProfit basis — owners-attributable PAT is ₹13.67 Cr (the basis for EPS ₹3.87) after a ₹(2.64) Lakh NCI deduction, and PBT already nets a ₹(25.32) Lakh share of associate loss. No exceptional items in the current or year-ago quarter, so the decline is purely operational. OPM is approximated as EBITDA margin (PBT-before-exceptional + finance cost + depreciation, over revenue from operations) since the filing doesn't disclose the DB's exact OPM formula.
Growth stalls, energy bleeds margins — the long-term bet wears thin
Management reaffirmed an 18% CAGR and margin-expansion roadmap, but Q2 delivered only 3.2% revenue growth and a 21.4% profit decline. A ₹4.78 crore energy and freight cost shock masks the underlying deterioration, and the market has already priced in skepticism.
₹238.16 Cr
+3.2% YoY vs 18% CAGR guidance
₹27.73 Cr
11.6% margin, -200 bps YoY
₹13.64 Cr
-21.4% YoY, -23.1% QoQ
On paper, 20 Microns delivered a 3.2% revenue growth and a 21.4% profit decline in Q2 — a quarter that was supposed to mark the company's return to momentum after two weak quarters. But the real story is simpler and more sobering: a ₹4.78 crore energy and freight cost shock — power up 33%, gas up 77%, freight up 11% — crushed operating leverage, and management's long-term hedges (solar plants, captive mines) remain years away from yielding relief.
The margin trap
Gross margin held firm at 47.7%, up a hair from 47.6% a year ago. That steadiness is real — it reflects a genuine shift toward specialty products, where 20 Microns now sources roughly one-third of revenue at higher markups. But the moment you descend to operating profit, the picture inverts: EBITDA margin fell 200 basis points to 11.6% from 13.8% a year prior, and net margin slid 150 bps to 5.7% from 7.2%. The culprit is unhedged input-cost inflation: power costs per kilogram rose from ₹42 to ₹56 (+33%), furnace gas from ₹69 to ₹122 per unit (+77%), and freight from ₹2,100 to ₹2,300 per metric tonne (+11%). In aggregate, that's a ₹4.78 crore drag on EBITDA — or roughly 200 basis points of the margin compression. None of that headwind has been hedged, and none is expected to reverse near-term.
Power costs ₹42→₹56/kg (33%, ₹1.34 Cr). Gas ₹69→₹122/kg (77%, ₹0.62 Cr). Freight ₹2.1→₹2.3K/MT (11%, ₹2.92 Cr). Total ₹4.78 Cr (200 bps). Solar will meet 40% of power by FY29, worth ~₹8 Cr EBITDA/yr.
What management said; what holds up
Revenue growth returned in Q2; we're back on track to an 18% CAGR.
3.2% YoY growth delivered, vs an 18% CAGR target. That's a 1.8x shortfall. At 3.2% annual growth, the company would reach only 7.6% cumulative CAGR over three years, not 18%. No path to 18% is visible without major acceleration.
Contradicted
Gross margin rose ~80 bps for the half; specialty products are now driving mix uplift.
Q2 gross margin at 47.7% vs 47.6% YoY — essentially flat, not expanding. Specialty product shift is real (now ~1/3 of revenue), but the mix lift is fully offset by unhedged energy and freight inflation. Operating margin fell 200 bps.
Overstated
The 18% CAGR is definitely achievable with CapEx and mining ramp.
Reaffirmed but hedged as 'should help us regain' — a retreat from prior confident tone. No near-term targets quantified. December mine start and Q4 solar commissioning still ahead; benefits deferred to FY29. Contingency language suggests management knows the near-term looks weak.
Supported but hedged
Specialty products are now ~1/3 of revenue with better margins; this mix shift is the real story.
Analyst estimate of 1/3 confirmed; high-margin grades (polymers, rubber, construction chemicals) growing double-digit per management. But PAT margin compressed YoY despite the mix shift. Specialty uplift not yet visible in group profitability — energy inflation is eating the gain.
Mixed
What changed on this call
Revenue growth guidance credibility eroded. Reaffirmed 18% CAGR but hedged as 'should help us regain' vs. prior definitive tone. Q2 delivered 3.2% YoY; no near-term acceleration visible.
Margin expansion guidance quietly dropped. Prior calls promised 200–250 bps EBITDA margin uplift within three years. This call did not reaffirm that target. Solar's ₹8 Cr annual benefit (80 bps) deferred to FY29. Near-term margin relief off the table.
CapEx transparency improved. Specific project names now disclosed: talc mine (Andhra Pradesh, ₹7 Cr), quartz/feldspar mine (Rajasthan, ₹7 Cr), 9 MW solar split across two plants (Rajasthan 5.5 MW, Gujarat 3.5 MW, ₹29 Cr), Malaysia specialty capacity expansion (ongoing). 30% deployed; remaining 70% over next 15–18 months.
Energy hedging remains absent. No disclosure of forward contracts, commodity futures, or insurance mechanisms to offset power/gas/freight inflation. Management focused on long-term mitigation (captive solar, mining) but left Q3–Q4 exposed.
The debate
The bull-bear ledger
Named ₹100 Cr CapEx with 30% deployed and project timelines disclosed (solar, mining, Malaysia)
Specialty product mix accelerating (polymers, rubber, construction chemicals all double-digit); 250+ grades now in portfolio
Gross margin resilience at 47.7% despite 33% power inflation and 77% gas inflation shows product mix shift is real
25-year customer relationships and DSIR-recognised R&D centre create competitive moat
Reported profit leans 100% on cost inflation narrative; no operational improvement visible
Q2 revenue +3.2% YoY vs 18% CAGR guidance — 1.8x shortfall with no visible path to acceleration
Paint segment (largest) flat YoY; customers raising retail prices but wholesale constrained — pricing power absent
Energy and freight cost inflation (₹4.78 Cr) unhedged; no forward contracts or insurance disclosed
All margin and growth upside deferred to FY29; near-term deterioration risk is material
FII ownership down to 0.41%, DII down to 0.07% — institutional disengagement accelerating
Risks, ranked by severity to a holder
Energy and freight inflation persists unhedged
High₹4.78 Cr (200 bps EBITDA) hit Q2 with zero forward contracts or hedges disclosed. If oil, LNG, and freight stay elevated through Q3–Q4 FY27, EBITDA margins could compress below 10%. Solar plants won't be live until Q4 FY27 at earliest. The company is naked to commodity exposure for another 6+ months.
Revenue growth stalls despite specialty product narrative
High3.2% YoY growth is structurally weak. Paint (largest segment) flat YoY despite price hikes. Specialty products (polymers, rubber) growing double-digit but not yet moving group revenue needle. If paint demand stays subdued and specialty uplift slows, the 18% CAGR target becomes impossible.
CapEx execution slips on mining ramp or solar commissioning
MediumDecember 2026 talc/quartz mine start and Q4 FY27 solar commissioning are the near-term catalysts. Any delay cascades: margin benefits pushed to FY28 or FY29, credibility further eroded, stock likely re-rates lower. The company has one shot to hit these timelines.
Raw-material import dependence (40%) amplifies geopolitical/tariff risk
MediumChina, Malaysia, Vietnam supply 40% of inputs. Tariff escalation, supply disruptions, or currency moves could spike costs further. Mining acquisitions will reduce import share to ~30% by FY29, but until then the company is exposed.
Pricing power remains capped by B2B pass-through limits
MediumPaint customers raised retail prices 3x in six months but constrain wholesale increases to 20M. Polymers, rubber, and specialty customers also cap pass-through. If input costs re-accelerate, margin compression will resume even with specialty mix uplift.
Institutional ownership collapse signals deeper skepticism
MediumFII down to 0.41% from prior 0.88%, DII down to 0.07% from 0.18%. Smart money is exiting or staying away. If institutions continue to trim, equity-market liquidity could suffer and re-rating lower could accelerate.
How the street is positioned — and what it means
The market has already rendered its verdict, and it's blunt: ₹162.85, down 53% from the all-time high of ₹346.7, and trading below every major moving average (SMA20 ₹186.6, SMA50 ₹202.84, SMA200 ₹186.63). The 52-week range is ₹130.5 to ₹238.1; the stock is now trading near its lows. Volume is increasing on the way down — a sign of institutional capitulation, not accumulation.
Ownership tells the same story: FII has shrunk to 0.41% from 0.88% a year ago, and DII is near-zero at 0.07% (down from 0.15–0.18% prior). Promoters still own 45%, but the lack of institutional interest is a red flag. Block-deal activity over the past six months shows mostly even buys and sells — no standout accumulation by marquee buyers, no signs of insider conviction. The stock is in the wilderness, and the earnings call did nothing to pull it back.
That said, the valuation discount is real. At current price, 20 Microns is trading at a trough multiple relative to its long-term ROIC target (18–20%) and the CapEx programme's expected IRR. But discounts persist for reasons: the market is pricing in two more quarters of weak growth and margin pressure before any catalyst fires. The Dec 2026 mine start and Q4 FY27 solar commissioning are the pivots — if those slip, the stock could trade lower still.
What to watch next
1 · Q3 FY27 (Dec 2026): Mining ramp and CapEx progress
Talc and quartz mines must start production as promised. CapEx should reach 50% deployed (₹50 Cr), with no schedule slippage. Any delay or cost overrun here signals execution risk and validates the bear case.
2 · Q4 FY27 (Mar 2027): Solar commissioning and margin guidance
9 MW captive solar plants must go live. Management must quantify the EBITDA benefit and commit to a near-term (FY28–FY29) margin expansion target. Vague language on timing or magnitude will further erode credibility.
3 · FY28 run-rate (Apr 2027–Mar 2028): Revenue acceleration and specialty product contribution
Specialty products must move from 'growing but not visible in group PAT' to a material margin contributor. Revenue growth must show signs of acceleration toward double-digits. If specialty uplift remains opaque and growth stays below 5%, the long-term narrative collapses.
20 Microns is in the midst of a multi-year CapEx and operational transformation. The pieces are named, the timelines are concrete, and the long-term ROCE uplift (to 18–20%) is plausible if execution holds. But the near-term is deteriorating: growth is stalled at 3.2% YoY, margins are compressed 200 bps by unhedged energy inflation, and all upside is deferred to FY29. Management reaffirmed the long-term narrative but hedged on near-term specifics — a signal of awareness that the path is narrowing.
The market has already priced in skepticism: the stock is down 53% from ATH, institutional ownership is collapsing, and volume is rising on the way down. The honest read is that this is a steady-execution story, not a step-change. A Hold is warranted: accumulate only on clear signs that the December mine ramp and Q4 solar commissioning are tracking, and that specialty product margin contribution is accelerating. The single number to track from here is organic revenue growth recovery — if that stays below 5% into FY28, the 18% CAGR target is a fantasy.